For All The Latest Medical News, Health News, Research News, COVID-19 News, Dengue News, Glaucoma News, Diabetes News, Herb News, Phytochemical News, Cardiology News, Epigenetic News, Cancer News, Doctor News, Hospital News

BREAKING NEWS
  Nov 11, 2018

Philips HeartStart FR2+ Defibrillator

Philips HeartStart FR2+ Defibrillator
  Nov 11, 2018


The therapy delivered by the HeartStart FR2+ is the most proven in the industry. More than 40 studies confirm its effectiveness. Philips’ high-current/low energy therapy ensures a potent defibrillation dose, while at the same time, minimizing side effects that may be harmful to a fragile heart. So the HeartStart FR2+ can deliver its most powerful therapy from the very first shock. There’s no need to hold back.

Capabilities and Features:

  • Automated defibrillation, with manual override (ECG model only)
  • SMART Analysis
  • SMART CPR and Quick Shock
  • Infant/child defibrillation
  • Conscious monitoring with optional FR2+ ECG Assessment Module
  • Optional rechargeable battery
  • Two display options: text-only, and text with ECG
  • Voice and text prompts
  • Over 8 hours of data collection
  • Programmable voice recording
  • Automated self-tests
  • "Ready-for-Use" indicator
  • Long-life battery: 300 shocks (minimum) or 12 hours monitoring
  • Pads can connect to most ALS defibrillator/monitors via pads adapters
For more detail: http://www.medical.philips.com/in_en/products/resuscitation/products/FR2plus/index.wpd
Request a Quote
for Philips HeartStart FR2+ Defibrillator